We recently published a list of Why These 15 Consumer Defensive Stocks Are Surging in 2025. In this article, we are going to take a look at where Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stands against other consumer defensive stocks that are surging in 2025.
The stock market has taken a sharp turn after two years of blockbuster gains, and many investors have felt uneasy. These investors are now turning to consumer defensive stocks due to growth stocks sputtering amid a new wave of tariffs rattling global trade.
Consumer defensive stocks provide essential goods and services that people rely on regardless of economic conditions and are more insulated during market downturns. Investors have piled into consumer defensive stocks for that reason, and it’s a good idea to look into the biggest winners in this sector.
Even during bear markets, there are pockets of the market that perform exceptionally well. For example, I identified Why These 15 Healthcare Stocks Are Surging in 2025 in another article.
Methodology
For this article, I screened the best-performing consumer defensive stocks year-to-date.
I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
vgstudio/Shutterstock.com
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH)
Number of Hedge Fund Holders In Q4 2024: 1
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) develops and sells private-label skincare products and operates franchise beauty stores, mainly in China.
The stock is up significantly so far in 2025, with the most significant driver being its successful initial public offering on December 27, 2024, where it raised $4.8 million at $4.00 per share. After the IPO, the stock surged rapidly.
The company’s rapid price appreciation is largely attributed to post-IPO momentum and heightened retail interest, particularly from overseas investors, as well as its niche positioning in the skincare market focused on solutions for problematic skin and a dual business model combining direct sales with franchise expansion.
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stock is up 119.08% year-to-date.
Overall, PHH ranks 3rd on our list of consumer defensive stocks that are surging in 2025. While we acknowledge the potential of PHH as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than PHH but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
